Physiomics to present on Personalized Medicine and Virtual Tumour at AACR 2021 Annual Meeting
Olav Hellebo, CEO of ReNeuron Group plc (RENE.L) Interview.
ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop ‘off the shelf’ stem cell treatments, without the need for immunosuppressive drugs. The Company’s
AI-driven chemistry retrosynthesis tool to advance drug discovery
In a bid to help to bring drugs to market for patients most in need, Elsevier, a global research publishing and information analytics provider.
Physiomics PLC (PYC.L) Conference presentation – AACR 2020 Virtual Meeting II
Physiomics to present on dual immuno-therapy at AACR 2020 Virtual Meeting II